Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial

Author:

Griese Matthias12ORCID,Costa Stefano3,Linnemann Rachel W.4,Mall Marcus A.56ORCID,McKone Edward F.7,Polineni Deepika8,Quon Bradley S.910,Ringshausen Felix C.1112ORCID,Taylor-Cousar Jennifer L.13ORCID,Withers Nicholas J.14ORCID,Moskowitz Samuel M.15,Daines Cori L.16

Affiliation:

1. Ludwig Maximilians UniversityMunich, Germany

2. German Center for Lung ResearchMunich, Germany

3. University of MessinaMessina, Italy

4. Emory UniversityAtlanta, Georgia

5. Charité–Universitätsmedizin BerlinBerlin, Germany

6. German Center for Lung ResearchBerlin, Germany

7. St. Vincent’s University HospitalDublin, Ireland

8. University of Kansas Medical CenterKansas City, Kansas

9. University of British ColumbiaVancouver, British Columbia, Canada

10. St. Paul’s HospitalVancouver, British Columbia, Canada

11. Hannover Medical SchoolHannover, Germany

12. German Center for Lung ResearchHannover, Germany

13. National Jewish HealthDenver, Colorado

14. Royal Devon and Exeter NHS Foundation TrustExeter, United Kingdom

15. Vertex Pharmaceuticals IncorporatedBoston, Massachusettsand

16. University of ArizonaTucson, Arizona

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3